133 related articles for article (PubMed ID: 29069756)
21. Suppression of TRPM7 inhibits proliferation, migration, and invasion of malignant human glioma cells.
Leng TD; Li MH; Shen JF; Liu ML; Li XB; Sun HW; Branigan D; Zeng Z; Si HF; Li J; Chen J; Xiong ZG
CNS Neurosci Ther; 2015 Mar; 21(3):252-61. PubMed ID: 25438992
[TBL] [Abstract][Full Text] [Related]
22. Hyperoxia resensitizes chemoresistant glioblastoma cells to temozolomide through unfolded protein response.
Lee D; Sun S; Ho AS; Kiang KM; Zhang XQ; Xu FF; Leung GK
Anticancer Res; 2014 Jun; 34(6):2957-66. PubMed ID: 24922660
[TBL] [Abstract][Full Text] [Related]
23. Bioinformatics analysis reveals disturbance mechanism of MAPK signaling pathway and cell cycle in Glioblastoma multiforme.
Li W; Li K; Zhao L; Zou H
Gene; 2014 Sep; 547(2):346-50. PubMed ID: 24967941
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells.
Bouterfa HL; Sattelmeyer V; Czub S; Vordermark D; Roosen K; Tonn JC
Anticancer Res; 2000; 20(4):2761-71. PubMed ID: 10953355
[TBL] [Abstract][Full Text] [Related]
25. EGFR activation results in enhanced cyclooxygenase-2 expression through p38 mitogen-activated protein kinase-dependent activation of the Sp1/Sp3 transcription factors in human gliomas.
Xu K; Shu HK
Cancer Res; 2007 Jul; 67(13):6121-9. PubMed ID: 17616668
[TBL] [Abstract][Full Text] [Related]
26. Guanylate binding protein-1 mediates EGFRvIII and promotes glioblastoma growth in vivo but not in vitro.
Lan Q; Wang A; Cheng Y; Mukasa A; Ma J; Hong L; Yu S; Sun L; Huang Q; Purow B; Li M
Oncotarget; 2016 Mar; 7(9):9680-91. PubMed ID: 26848767
[TBL] [Abstract][Full Text] [Related]
27. Notch1 promotes glioma cell migration and invasion by stimulating β-catenin and NF-κB signaling via AKT activation.
Zhang X; Chen T; Zhang J; Mao Q; Li S; Xiong W; Qiu Y; Xie Q; Ge J
Cancer Sci; 2012 Feb; 103(2):181-90. PubMed ID: 22093097
[TBL] [Abstract][Full Text] [Related]
28. PDGFR-β-activated ACK1-AKT signaling promotes glioma tumorigenesis.
Zhang J; Chen T; Mao Q; Lin J; Jia J; Li S; Xiong W; Lin Y; Liu Z; Liu X; Zhao H; Wang G; Zheng D; Qiu S; Ge J
Int J Cancer; 2015 Apr; 136(8):1769-80. PubMed ID: 25257795
[TBL] [Abstract][Full Text] [Related]
29. Up-Regulation of microRNA-183 Promotes Cell Proliferation and Invasion in Glioma By Directly Targeting NEFL.
Wang ZY; Xiong J; Zhang SS; Wang JJ; Gong ZJ; Dai MH
Cell Mol Neurobiol; 2016 Nov; 36(8):1303-1310. PubMed ID: 26879754
[TBL] [Abstract][Full Text] [Related]
30. Let-7g-5p inhibits epithelial-mesenchymal transition consistent with reduction of glioma stem cell phenotypes by targeting VSIG4 in glioblastoma.
Zhang XH; Qian Y; Li Z; Zhang NN; Xie YJ
Oncol Rep; 2016 Nov; 36(5):2967-2975. PubMed ID: 27634309
[TBL] [Abstract][Full Text] [Related]
31. LAP3 promotes glioma progression by regulating proliferation, migration and invasion of glioma cells.
He X; Huang Q; Qiu X; Liu X; Sun G; Guo J; Ding Z; Yang L; Ban N; Tao T; Wang D
Int J Biol Macromol; 2015 Jan; 72():1081-9. PubMed ID: 25453285
[TBL] [Abstract][Full Text] [Related]
32. Activation of p38 MAPK and/or JNK contributes to increased levels of VEGF secretion in human malignant glioma cells.
Yoshino Y; Aoyagi M; Tamaki M; Duan L; Morimoto T; Ohno K
Int J Oncol; 2006 Oct; 29(4):981-7. PubMed ID: 16964394
[TBL] [Abstract][Full Text] [Related]
33. R132H mutation in IDH1 gene reduces proliferation, cell survival and invasion of human glioma by downregulating Wnt/β-catenin signaling.
Cui D; Ren J; Shi J; Feng L; Wang K; Zeng T; Jin Y; Gao L
Int J Biochem Cell Biol; 2016 Apr; 73():72-81. PubMed ID: 26860959
[TBL] [Abstract][Full Text] [Related]
34. Hypotaurine evokes a malignant phenotype in glioma through aberrant hypoxic signaling.
Gao P; Yang C; Nesvick CL; Feldman MJ; Sizdahkhani S; Liu H; Chu H; Yang F; Tang L; Tian J; Zhao S; Li G; Heiss JD; Liu Y; Zhuang Z; Xu G
Oncotarget; 2016 Mar; 7(12):15200-14. PubMed ID: 26934654
[TBL] [Abstract][Full Text] [Related]
35. Hypermethylation of the
Wu X; Ouyang Y; Wang B; Lin J; Bai Y
Cancer Manag Res; 2020; 12():7043-7059. PubMed ID: 32848462
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of tissue factor/protease-activated receptor-2 signaling limits proliferation, migration and invasion of malignant glioma cells.
Gessler F; Voss V; Dützmann S; Seifert V; Gerlach R; Kögel D
Neuroscience; 2010 Feb; 165(4):1312-22. PubMed ID: 19958818
[TBL] [Abstract][Full Text] [Related]
37. MAGI3 negatively regulates Wnt/β-catenin signaling and suppresses malignant phenotypes of glioma cells.
Ma Q; Yang Y; Feng D; Zheng S; Meng R; Fa P; Zhao C; Liu H; Song R; Tao T; Yang L; Dai J; Wang S; Jiang WG; He J
Oncotarget; 2015 Nov; 6(34):35851-65. PubMed ID: 26452219
[TBL] [Abstract][Full Text] [Related]
38. Rho/ROCK and MAPK signaling pathways are involved in glioblastoma cell migration and proliferation.
Zohrabian VM; Forzani B; Chau Z; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2009 Jan; 29(1):119-23. PubMed ID: 19331140
[TBL] [Abstract][Full Text] [Related]
39. The D Domain of LRRC4 anchors ERK1/2 in the cytoplasm and competitively inhibits MEK/ERK activation in glioma cells.
Wang Z; Guo Q; Wang R; Xu G; Li P; Sun Y; She X; Liu Q; Chen Q; Yu Z; Liu C; Xiong J; Li G; Wu M
J Hematol Oncol; 2016 Nov; 9(1):130. PubMed ID: 27884160
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9.
Liu N; Zhang L; Wang Z; Cheng Y; Zhang P; Wang X; Wen W; Yang H; Liu H; Jin W; Zhang Y; Tu Y
Oncotarget; 2017 Mar; 8(12):19244-19254. PubMed ID: 27911279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
